Low serum 25(OH)D3 in patients newly diagnosed with T2DM

Low serum 25(OH)D<sub>3</sub> in patients newly diagnosed with T2DM

(HealthDay)—Serum 25-hydroxyvitamin D3 (25[OH]D3) is associated with glucose-stimulated insulin secretion and β-cell function in individuals with newly diagnosed type 2 diabetes, according to a study published online June 5 in the Journal of Diabetes Investigation.

Yan Yang, from the Sichuan Provincial People's Hospital in Chengdu, China, and colleagues recruited 97 newly diagnosed type 2 diabetes patients and 69 healthy controls to assess 25(OH)D3. The authors determined 25(OH)D3 using high pressure liquid chromatography. The correlations of 25(OH)D3 with insulin resistance and β- were assessed.

The researchers found that patients with newly diagnosed had much lower serum 25(OH)D3 (P < 0.01); the prevalence of hypovitaminosis 25(OH)D3 in patients with diabetes was 62.9 percent. Among patients with diabetes, those with hypovitaminosis 25(OH)D3 had higher hemoglobin A1c (HbA1c) and area under the curve for glucose (P < 0.01) and lower homeostasis model of assessment (HOMA)-β, early-phase index, and area under the insulin curve. There was an independent positive correlation for serum 25(OH)D3 with early-phase insulin secretion index and area under the insulin curve (P < 0.05), but not with HOMA-insulin resistance or HOMA-β. In both groups, triglycerides, HbA1c, and early-phase insulin secretion index were independent factors associated with serum 25(OH)D3.

"Serum 25(OH)D3 is not correlated with basal or β-cell function but is significantly positively correlated with glucose-stimulated insulin secretion and β-cell function," the authors write.

More information: Abstract
Full Text

Copyright © 2015 HealthDay. All rights reserved.

Citation: Low serum 25(OH)D3 in patients newly diagnosed with T2DM (2015, June 15) retrieved 4 June 2023 from https://medicalxpress.com/news/2015-06-serum-25ohd3-patients-newly-t2dm.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Gender-based differences in glycemic control in T2DM


Feedback to editors